Cite
HARVARD Citation
Dinami, R. et al. (2023). MiR‐182‐3p targets TRF2 and impairs tumor growth of triple‐negative breast cancer. EMBO molecular medicine. 15 (1), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dinami, R. et al. (2023). MiR‐182‐3p targets TRF2 and impairs tumor growth of triple‐negative breast cancer. EMBO molecular medicine. 15 (1), p. n/a. [Online].